Position in PAHC
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$470,798
+$152,790 QoQ
Shares Held
8,512
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $1,320,238,974 across 27 Drug Manufacturers - Specialty & Generic names. PAHC ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,701,747 | $437,583,511 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
4,774,841 | $362,171,687 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,816,657 | $145,077,707 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,908,506 | $84,808,976 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
4,986,073 | $69,306,414 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
466,977 | $61,519,549 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,825,651 | $60,374,277 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
2,094,270 | $36,628,782 |
All Filings in PAHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $470,798 | 8,512 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $318,008 | 8,512 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $344,395 | 8,512 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $217,396 | 8,512 | Shares | Defined | 2025-08-14 | |
| 2020-12-31 | $14,372,450 | 740,085 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $12,877,479 | 740,085 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $21,231,466 | 808,202 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,440,288 | 680,194 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||